MC
MDT icon

Muhlenkamp & Co’s Medtronic MDT Stock Holding History

Muhlenkamp & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-173,364
Closed -$11.6M – 65
2015
Q3 		$11.6M Sell
173,364
-386
-0.2% -$28.4K 3.41% 12
2015
Q2 		$12.9M Buy
173,750
+97
+0.1% +$7.41K 2.79% 13
2015
Q1 		$13.5M Buy
+173,653
New +$13.2M 2.85% 15

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Muhlenkamp & Co's MDT Position: Q4 2015 in Review

Muhlenkamp & Co sold out of Medtronic (MDT) in Q4 2015, closing a stake of 173,364 shares — an estimated $11.6M sold.

Muhlenkamp & Co first reported a position in MDT in Q1 2015 and held it in 3 quarters. The position peaked at $13.5M in Q1 2015. 1,251 funds tracked by Wall St. Rank hold MDT as of Q4 2015.

  • Muhlenkamp & Co reported no remaining Medtronic position as of Q4 2015 after selling out during the quarter.
  • Muhlenkamp & Co sold 173,364 Medtronic shares in Q4 2015, an estimated $11.6M.
  • Muhlenkamp & Co first reported a position in Medtronic in Q1 2015 and held it in 3 quarters.
  • Muhlenkamp & Co's Medtronic position peaked at $13.5M in Q1 2015.
  • 1,251 funds tracked by Wall St. Rank held Medtronic as of Q4 2015.

Based on Muhlenkamp & Co's 13F filing for Q4 2015, filed 10 Feb 2016.